Area of research
Genetics · Hematology
Research interest
Research interests include Medicine, Hereditary angioedema, Angioedema, Placebo, C1-inhibitor, and Adverse effect.
Pharmacokinetics and Pharmacodynamics of neffy, Epinephrine Nasal Spray, in Pediatric Allergy Patients
Lanadelumab in Patients 2 to Less Than 12 Years Old With Hereditary Angioedema: Results From the Phase 3 SPRING Study
Assessment and management of disease burden and quality of life in patients with hereditary angioedema: a consensus report
Consensus on treatment goals in hereditary angioedema: A global Delphi initiative
Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study
US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema
Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial
Subcutaneous C1 inhibitor for prevention of attacks of hereditary angioedema: additional outcomes and subgroup analysis of a placebo-controlled randomized study
Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks
Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema
Inhibiting Plasma Kallikrein for Hereditary Angioedema Prophylaxis